Population pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections: experience with heterogeneous pharmacokinetic data.
about
Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patientsFundamentals of population pharmacokinetic modelling: validation methods.Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumours.
P2860
Population pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections: experience with heterogeneous pharmacokinetic data.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@ast
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@en
type
label
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@ast
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@en
prefLabel
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@ast
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@en
P2093
P1476
Population pharmacokinetics of ...... ogeneous pharmacokinetic data.
@en
P2093
P304
P356
10.2165/00003088-200140040-00006
P577
2001-01-01T00:00:00Z
P6179
1035199208